
Ravinder Rana
About Ravinder Rana
Data last updated:
Ravinder Rana has 12 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Agond Lifesciences Private Limited and Nowry Lifesciences Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Agond Lifesciences Private Limited at ₹2.59 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Nov 2013 | 2013 | ₹2.59 Cr (FY 2025) | Active | |
| Designated Partner | 23 Jun 2016 | 2016 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravinder Rana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravinder Rana
Ravinder Rana has 12 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Agond Lifesciences Private Limited and Nowry Lifesciences Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Agond Lifesciences Private Limited at ₹2.59 Cr (FY 2025).
Ravinder Rana is associated with 2 companies as Director and Designated Partner, including Agond Lifesciences Private Limited (₹2.59 Cr), Nowry Lifesciences Llp.
Ravinder Rana has expertise in General Business.
Ravinder Rana has 12 years in corporate governance.
By reported revenue, the largest current company of Ravinder Rana is Agond Lifesciences Private Limited, with revenue of ₹2.59 Cr (FY 2025).
Ravinder Rana currently holds positions at 2 companies: Agond Lifesciences Private Limited (₹2.59 Cr), Nowry Lifesciences Llp.